Show simple item record

dc.contributor.authorKhairy, H.
dc.contributor.authorHoussen, Wael E
dc.date.accessioned2013-02-11T11:38:00Z
dc.date.available2013-02-11T11:38:00Z
dc.date.issued2010-01-01
dc.identifier.citationKhairy , H & Houssen , W E 2010 , ' Inactivation of anandamide signaling : A continuing Debate ' , Pharmaceuticals , vol. 3 , no. 11 , pp. 3355-3370 . https://doi.org/10.3390/ph3113355en
dc.identifier.issn1424-8247
dc.identifier.otherPURE: 20046078
dc.identifier.otherPURE UUID: eb16ab7e-962a-4121-a0ca-220cf2df612f
dc.identifier.otherScopus: 78650319514
dc.identifier.urihttp://hdl.handle.net/2164/2629
dc.descriptionCopyright 2011 Elsevier B.V., All rights reserved.en
dc.format.extent16
dc.language.isoeng
dc.relation.ispartofPharmaceuticalsen
dc.rightsKhairy, H & Houssen, WE 2010, 'Inactivation of anandamide signaling: A continuing Debate' Pharmaceuticals, vol 3, no. 11, pp. 3355-3370.en
dc.subjectendocannabinoid inactivationen
dc.subjectanandamideen
dc.subjectethanolamineen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleInactivation of anandamide signaling : A continuing Debateen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3390/ph3113355
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=78650319514&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record